Cipla news: Cipla eyes acquisitions, inorganic partnerships in US market
Drug main Cipla is eyeing acquisitions and inorganic partnerships within the US market whereas consolidating its presence throughout segments within ...
Drug main Cipla is eyeing acquisitions and inorganic partnerships within the US market whereas consolidating its presence throughout segments within ...
MUMBAI: Cipla stated it expects to finish FY24 with the earnings earlier than curiosity, tax, depreciation and ammortisation (Ebitda) margins ...
New Delhi, Drug main Cipla on Sunday mentioned its subsidiary is voluntarily recalling one lot of treatment within the US ...
The US well being regulator has pulled up drug main Cipla for numerous manufacturing lapses at its Pithampur (Madhya Pradesh) ...
Torrent Pharma’s bid to amass the stake of the promoter, the Hamied household, in Cipla has stalled over valuation variations, ...
Torrent Prescribed drugs Ltd is in superior negotiations with CVC Capital Companions to kind a consortium and lift a minimum ...
The sale of a stake in Cipla Ltd. is in jeopardy as potential patrons have balked on the 1.09 trillion ...
US buyout group Bain Capital has approached Dr Reddy's Laboratories (DRL) to discover a joint bid to purchase out the ...
Indian drugmaker Cipla mentioned on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol attributable to ...
Main drug corporations Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling totally different merchandise within the US marketplace for ...
Copyright © 2022 Asia Today.